title: Requirement for microtubules and dynein motors in the earliest stages of peroxisome biogenesis.
abstract: Our aim was to determine the role of microtubules in the biogenesis of peroxisomes. Fusion experiments between human PEX16- and PEX1-mutant cells in the presence of nocodazol implied that microtubules were not required for import of proteins into the peroxisomal matrix after cell fusion complementation. We further studied the importance of microtubules in the early stages of peroxisome biogenesis following the microinjection complementation of PEX16-mutant cells. In the absence of nocodazol, nuclear microinjection of plasmids expressing EGFP-SKL and Pex16p in PEX16-mutant cells resulted in the accumulation of EGFP-SKL into newly formed peroxisomes. However, pretreatment of the cells with nocodazol, prior to microinjection, resulted in the inhibition of complementation of the PEX16 mutant and the cytosolic location of the EGFP-SKL. In addition, coexpression of a dominant-negative CC1 subunit of the dynein/dynactin motor complex resulted in the inability to complement PEX16-mutant cells. Both of these treatments resulted in the cytosolic localization of expressed Pex16p. Our results demonstrate that the formation of peroxisomes via the preperoxisomal compartment is dependent upon microtubules and minus-end-directed motor proteins and that the inhibition described above occurs at a step that precedes the association of Pex16p with the vesicles that would otherwise become the peroxisomes.
authors.affiliation: Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, Canada N6A 5C1.
authors.forename: Cécile B
authors.initials: CB
authors.lastname: Brocard
authors.forename: Krissy K
authors.initials: KK
authors.lastname: Boucher
authors.forename: Christopher
authors.initials: C
authors.lastname: Jedeszko
authors.forename: Peter K
authors.initials: PK
authors.lastname: Kim
authors.forename: Paul A
authors.initials: PA
authors.lastname: Walton
mesh_terms: D002459:Cell Fusion; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D000072159:Dynactin Complex; D004398:Dyneins / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism; D005816:Genetic Complementation Test; D049452:Green Fluorescent Proteins / Q000096:biosynthesis; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D008845:Microinjections; D008856:Microscopy, Fluorescence; D008869:Microtubule-Associated Proteins / Q000378:metabolism*; D008870:Microtubules / Q000378:metabolism*; D009154:Mutation; D015739:Nocodazole / Q000494:pharmacology; D020675:Peroxisomes / Q000378:metabolism*; D013997:Time Factors; D015211:Zellweger Syndrome / Q000235:genetics / Q000378:metabolism
chemical_list: D000072159:Dynactin Complex; D008565:Membrane Proteins; D008869:Microtubule-Associated Proteins; C486345:PEX16 protein, human; D049452:Green Fluorescent Proteins; D004398:Dyneins; D015739:Nocodazole